Literature DB >> 29157660

Encephalitis and myelitis in tropical countries: Report from the Task Force on Tropical Diseases by the World Federation of Societies of Intensive and Critical Care Medicine.

Gisele Sampaio Silva1, Guy A Richards2, Tim Baker3, Pravin R Amin4.   

Abstract

Tropical diseases are those that occur primarily or solely in the tropics, and as such include infectious diseases that are particularly prevalent in hot, humid conditions. The incidence of encephalitis in tropical countries is reported to be as high as 6.34/100,000/year. The term encephalitis implies inflammation of the brain and includes the presence of encephalopathy with two and more of the following features: fever, seizures and/or focal neurological findings; a cerebrospinal fluid pleocytosis; electroencephalographic findings or abnormal neuroimaging suggestive of encephalitis. Transverse myelitis (TM) is an inflammation of the spinal cord which has a wide variety of clinical presentations depending on the degree (severity of myelin and neuronal injury) and site of spinal cord involvement. In the present article we discuss the various forms of tropical, viral encephalitides and myelitis and the diagnosis and management.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arbovirus; Encephalitis; Myelitis; Tropical countries

Mesh:

Year:  2017        PMID: 29157660     DOI: 10.1016/j.jcrc.2017.11.001

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  1 in total

1.  Central nervous system infection in the intensive care unit: Development and validation of a multi-parameter diagnostic prediction tool to identify suspected patients.

Authors:  Hugo Boechat Andrade; Ivan Rocha Ferreira da Silva; Justin Lee Sim; José Henrique Mello-Neto; Pedro Henrique Nascimento Theodoro; Mayara Secco Torres da Silva; Margareth Catoia Varela; Grazielle Viana Ramos; Aline Ramos da Silva; Fernando Augusto Bozza; Jesus Soares; Ermias D Belay; James J Sejvar; José Cerbino-Neto; André Miguel Japiassú
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.